Close
APE 2026

AIIMS and IIIT-Delhi sign MoU to advance digital health technologies

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Abbott to Acquire Cancer Test Maker...

In a recent move, Abbott has gone ahead and...

New Policy to Boost Medical Device...

Beijing has gone on to release a new policy...

US Lawmakers Push Access For AI-Powered...

The US bipartisan legislation, which was introduced in the...

The All India Institute of Medical Sciences (AIIMS) and the Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) have signed a Memorandum of Understanding (MoU) to work on various aspects of digital health areas jointly. Under the MoU, IIIT-Delhi, and AIIMS will work together in areas such as artificial intelligence (AI), machine learning (ML), and computational genomics for advancing clinical medicine, public health, and biomedical research, the institute said.

“The focus of the collaboration will be on improving patient care, outcomes, and healthcare delivery through the development of innovative technologies. The two institutions will also engage in joint research and training, the exchange of faculty and students, and the organization of workshops and seminars to promote collaboration in the field of digital health,” IIIT Delhi said.

The collaboration will focus on solving the major health challenges facing India such as access to healthcare in remote and underserved areas by building technology innovations in m-Health, artificial intelligence, interoperability, cybersecurity, and allied areas. AIIMS and IIIT Delhi will also work together on computational genomics research, which will be used to advance the understanding of the genomic basis of human diseases and inform the development of personalised treatments.

 

 

Latest stories

Related stories

Abbott to Acquire Cancer Test Maker for Around $21 Billion

In a recent move, Abbott has gone ahead and...

New Policy to Boost Medical Device Industry in China

Beijing has gone on to release a new policy...

US Lawmakers Push Access For AI-Powered Medical Devices

The US bipartisan legislation, which was introduced in the...

$622m Government Plan for South Korea Medical Device Sector

The South Korea Medical Device Sector is all set...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »